Saturday 24th March, 2018
35 ℉ | 51 ℉Raleigh

Durham company sets terms of $69M IPO

Business Journal - Tuesday 20th June, 2017

Durham-based Dova Pharmaceuticals disclosed in a filing with the SEC on Monday that it will offer 4,062,500 shares of common stock in its initial public offering, at a price of between $15 and $17 per share. The company has applied to list its stock on the Nasdaq exchange under the ticker symbol DOVA.

Dova ' formed in March 2016 ' acquired its drug candidate avatrombopag from Eisai that same month. After completing a pair of successful Phase 3 clinical trials, the company said in the filing...

Read More

More North Carolina State News

Access More
Loading data...


North Carolina State News.Net



North Carolina State News.Net

Sign up for North Carolina State News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!